American society of nephrology quiz and questionnaire 2012: Glomerulonephritis

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 8, 2013, Pages 1460-1465

  Fervenza, Fernando C ^a   Glassock, Richard J ^b   Bleyer, Anthony J ^c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BETA 2 MICROGLOBULIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G4; LISINOPRIL; METHYLPREDNISOLONE; PREDNISONE;

ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; EDUCATION; ELECTRON MICROSCOPY; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HEMATURIA; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY BIOPSY; KIDNEY VEIN THROMBOSIS; NEPHROLOGY; NEUTROPHIL CHEMOTAXIS; PROTEINURIA; QUESTIONNAIRE; TRAINING; UNITED STATES; URINALYSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; MIDDLE AGED; NEPHROLOGY; QUESTIONNAIRES; SOCIETIES, MEDICAL;

EID: 84881249107     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00440113     Document Type: Article

References (53)

1. Rodriguez-Iturbe B, Musser JM: The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 19: 1855-1864, 2008.
2. Eison TM, Ault BH, Jones DP, Chesney RW, Wyatt RJ: Poststreptococcal acute glomerulonephritis in children: Clinical features and pathogenesis. Pediatr Nephrol 26: 165-180, 2011.
3. Nasr SH, Fidler ME, Valeri AM, Cornell LD, Sethi S, Zoller A, Stokes MB, Markowitz GS, D'Agati VD: Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol 22: 187-195, 2011.
4. Nasr SH, Markowitz GS, Stokes MB, Said SM, Valeri AM, D'Agati VD: Acute postinfectious glomerulonephritis in the modern era: Experience with 86 adults and review of the literature. Medicine (Baltimore) 87: 21-32, 2008.
5. Montseny JJ, Meyrier A, Kleinknecht D, Callard P: The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature. Medicine (Baltimore) 74: 63-73, 1995.
6. Nasr SH, Radhakrishnan J, D'Agati VD: Bacterial infectionrelated glomerulonephritis in adults [published online ahead of print January 9, 2013]. Kidney Int doi: 10.1038/ki.2012.407.
7. Nadasdy T, Hebert LA: Infection-related glomerulonephritis: Understanding mechanisms. Semin Nephrol 31: 369-375, 2011.
8. Yousif Y, Okada K, Batsford S, Vogt A: Induction of glomerulonephritis in rats with staphylococcal phosphatase: New aspects in post-infectious ICGN. Kidney Int 50: 290-297, 1996.
9. Rodríguez-Iturbe B, Batsford S: Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 71: 1094-1104, 2007.
10. Madaio MP, Harrington JT: Current concepts. The diagnosis of acute glomerulonephritis. N Engl J Med 309: 1299-1302, 1983.
11. Rodríguez-Iturbe B: Epidemic poststreptococcal glomerulonephritis. Kidney Int 25: 129-136, 1984.
12. Fremeaux-Bacchi V, Weiss L, Demouchy C, May A, Palomera S, Kazatchkine MD: Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity. Nephrol Dial Transplant 9: 1747-1750, 1994.
13. Daha MR, Austen KF, Fearon DT: Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor. J Immunol 120: 1389-1394, 1978.
14. Hoy WE, White AV, Dowling A, Sharma SK, Bloomfield H, Tipiloura BT, Swanson CE, Mathews JD, McCredie DA: Poststreptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int 81: 1026-1032, 2012.
15. Dedeoglu IO, Springate JE, Waz WR, Stapleton FB, Feld LG: Prolonged hypocomplementemia in poststreptococcal acute glomerulonephritis. Clin Nephrol 46: 302-305, 1996.
16. Baldwin DS, Gluck MC, Schacht RG, Gallo G: The long-term course of poststreptococcal glomerulonephritis. Ann Intern Med 80: 342-358, 1974.
17. Popovic-Rolovic M: Serum C3 levels in acute glomerulonephritis and postnephritic children. Arch Dis Child 48: 622-626, 1973.
18. Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ: Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83: 293-299, 2013.
19. Sandhu G, Bansal A, Ranade A, Jones J, Cortell S, Markowitz GS: C3 glomerulopathy masquerading as acute postinfectious glomerulonephritis. Am J Kidney Dis 60: 1039-1043, 2012.
20. Vernon KA, Goicoechea de Jorge E, Hall AE, Fremeaux-Bacchi V, Aitman TJ, Cook HT, Hangartner R, Koziell A, Pickering MC et al Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis 60: 121-125, 2012.
21. Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ: C3 glomerulonephritis: Clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int 82: 465-473, 2012.
22. Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F: Primary glomerulonephritis with isolated C3 deposits: A new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44: 193-199, 2007.
23. Sethi S, Fervenza FC: Membranoproliferative glomerulonephritis- a new look at an old entity. N Engl J Med 366: 1119-1131, 2012.
24. Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ: Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 6: 1009-1017, 2011.
25. Sethi S, Nester CM, Smith RJ: Membranoproliferative glomerulonephritis and C3 glomerulopathy: Resolving the confusion. Kidney Int 81: 434-441, 2012.
26. Rodríguez-Iturbe B, Rubio L, García R: Attack rate of poststreptococcal nephritis in families. A prospective study. Lancet 1: 401-403, 1981.
27. Medawar W, Green A, Campbell E, Carmody M, Donohoe J, Doyle G, Walshe JJ: Clinical and histopathologic findings in adults with the nephrotic syndrome. Ir J Med Sci 159: 137-140, 1990.
28. Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi G: Rituximab in idiopathic membranous nephropathy: A one-year prospective study. J Am Soc Nephrol 14: 1851-1857, 2003.
29. Cattran DC: Idiopathicmembranous glomerulonephritis. Kidney Int 59: 1983-1994, 2001.
30. Wagoner RD, Stanson AW, Holley KE, Winter CS: Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: Incidence and significance. Kidney Int 23: 368-374, 1983.
31. Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH: The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 44: 638-642, 1993.
32. Wheeler DC, Bernard DB: Lipid abnormalities in the nephrotic syndrome: Causes, consequences, and treatment. Am J Kidney Dis 23: 331-346, 1994.
33. Fervenza FC, Sethi S, Specks U: Idiopathic membranous nephropathy: Diagnosis and treatment. Clin J Am Soc Nephrol 3: 905-919, 2008.
34. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G: Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 17: 1890-1896, 2002.
35. Branten AJ, du Buf-Vereijken PW, Klasen IS, Bosch FH, Feith GW, Hollander DA, Wetzels JF: Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am SocNephrol 16: 169-174, 2005.
36. Hofstra JM, Deegens JK, Willems HL, Wetzels JF: Beta-2- microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant 23: 2546-2551, 2008.
37. du Buf-Vereijken PW, Wetzels JF: Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency. Nephrol Dial Transplant 21: 389-396, 2006.
38. Irazabal MV, Eirin A, Lieske J, Beck LH, Sethi S, Borland TM, Dillon JJ, Nachman PH, Nasr SH, Cornell LD, Leung N, Cattran DC, Fervenza FC: Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: A prospective study. Nephrol Dial Transplant 28: 137-146, 2013.
39. Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, Yamamoto M, Takahashi H, Matsui S, Nakada S, Origuchi T, Hirabayashi A, Homma N, Tsubata Y, Takata T, Wada Y, Saito A, Fukase S, Ishioka K, Miyazaki K, Masaki Y, Umehara H, Sugai S, Narita I: Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 78: 1016-1023, 2010.
40. Stone JH, Zen Y, Deshpande V: IgG4-related disease. N Engl J Med 366: 539-551, 2012.
41. Cornell LD, Chicano SL, Deshpande V, Collins AB, Selig MK, Lauwers GY, Barisoni L, Colvin RB: Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 31: 1586-1597, 2007.
42. Kamisawa T, Okamoto A: IgG4-related sclerosing disease.World J Gastroenterol 14: 3948-3955, 2008.
43. Cravedi P, Abbate M, Gagliardini E, Galbusera M, Buelli S, Sabadini E, Marasa M, Beck LH Jr, Salant DJ, Benigni A, D'Agati V, Remuzzi G: Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis 58: 272-275, 2011.
44. Fervenza FC, Downer G, Beck LH Jr, Sethi S: IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis 58: 320-324, 2011.
45. Llach F: Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 28: 429-439, 1985.
46. Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, Hladunewich M, Greenwald A, Hu Y, Jennette CE, Jennette JC, Falk RJ, Cattran DC, Nachman PH, Reich HN: Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol 7: 43-51, 2012.
47. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009.
48. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22: 1137-1143, 2011.
49. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ: Rituximabinduced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22: 1543-1550, 2011.
50. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ: Antiphospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286-1291, 2011.
51. Herrmann SM, Sethi S, Fervenza FC: Membranous nephropathy: The start of a paradigm shift. Curr Opin Nephrol Hypertens 21: 203-210, 2012.
52. Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF: Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23: 1735-1743, 2012.
53. Debiec H, Ronco P: PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl JMed 364: 689-690, 2011